Magdalene Corona

16PUBLICATIONS
87CO-AUTHORS
Predictive and prognostic markersTumour immunologyMedical bacteriologyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 31, 2026
Tumor CD19 Expression Determines Distinct Clinical Outcomes After CD19 CAR T-Cell Therapy in Large B-Cell Lymphoma.

|May 20, 2026
Real-World Evaluation of Talquetamab for the Treatment of Relapsed/Refractory Multiple Myeloma (RRMM): An International Myeloma Working Group Immunotherapy Registry Real-World Analysis.

|Mar 06, 2026
Antibiotic-associated dysbiosis and bispecific antibody outcomes in multiple myeloma.

Magdalena Corona, Roberto García-Vicente, Adolfo Jesús Saez-Marin

|Nov 18, 2025
Late hematologic toxicity after CAR T-cell therapy in large B-cell lymphoma: incidence, risk factors, and clinical impact.

Magdalena Corona, Samantha Brown, Kai Rejeski

|Aug 26, 2025
Optimization and validation of the international metabolic prognostic index for CD19 CAR-T in large B-cell lymphoma.

Michael Winkelmann, Sandeep S Raj, Michael D Jain

|Aug 15, 2025
Comparative real-world outcomes of CD19-directed CAR T-cell therapies in large B-cell lymphoma.

Xavier Deschênes-Simard, Maria Bromberg, Sean M Devlin

Pageof 3

Frequent Collaborators

7 joint publications

Roni Shouval

7 joint publications

Miguel-Angel Perales

6 joint publications

Sara Rodríguez-Mora

6 joint publications

Gilles Salles